http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103060315-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c821adab4a045b72f43449186b20dfba |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2012-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34fa62dc7762fd95a30be94917e8646a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6574a4d11e90d8340ee09a4ad75f12fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f119a28c8aff683078aa9ecdf72bb0e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce1d50674103da7a8f164d6116c6fa2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1954089c57cb47d279bc987cab1a1343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e929bab0360a988eb5a7ecde6fbc7a57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e4c1b070afed4892ebee77d99929f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090ce1a9efa88a5b8196749e6392171a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad416b76061b508c044bacbeca324e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff32576d5f761993237ba8b2e7d3d1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecdec876d0a1f49853a3174ce84b82b |
| publicationDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103060315-B |
| titleOfInvention | Detection kit and method for predicting susceptibility to prostate cancer |
| abstract | The invention discloses a detection kit and a method for predicting susceptibility to prostate cancer, belonging to the field of biotechnology. The detection kit and the method can be used for predicting susceptibility of a subject to prostate cancer by extracting the genomic deoxyribonucleic acid (DNA) of host cells and testing the genotype of the rs4714476 site near 5' end of FOXP 4 gene of the subject; when the genotype of the rs4714476 near 5' end of the FOXP 4 gene is CC or TC, the susceptibility of the subject to prostate cancer is higher; when the genotype of the rs4714476 is TT, the susceptibility of the subject to prostate cancer is the lowest; and the clinical phenotype of the prostate cancer of the subject can be predicted. The occurrence rates of neoplasm staging III and advanced prostate cancer of the patients with the genotype of CC or TC are apparently higher than those of the patients with the genotype of TT. The detection kit and the method have the advantages that the correlation between rs4714476 gene polymorphic site and prostate cancer as well as the clinical information of prostate cancer is expounded for the first time; the method for predicting the susceptibility to prostate cancer is provided; and the method can be used for early prevention diagnosis and auxiliary diagnosis of prostate cancer, and is also used for research and development of new medicines. |
| priorityDate | 2012-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.